Patents, Bio Rad Laboratories Inc, 10x Genomics, Microfluidics, Single Cell Sequencing.
acquisition of QuantaLife, it is believed that the acquisition is mostly driven by the desire for Rain Dance’s patent portfolio. Following the acquisition, Bio Rad became the plaintiff against 10X. What happened to Rain Dance’s ddPCR and single-cell product? How about their existing customers?